title: Sjögren's syndrome and aromatase inhibitors treatment: is there a link?
authors.forename: Giacomo Maria
authors.initials: GM
authors.lastname: Guidelli
authors.forename: Ignazio
authors.initials: I
authors.lastname: Martellucci
authors.forename: Mauro
authors.initials: M
authors.lastname: Galeazzi
authors.forename: Guido
authors.initials: G
authors.lastname: Francini
authors.forename: Antonella
authors.initials: A
authors.lastname: Fioravanti
mesh_terms: D000368:Aged; D000077384:Anastrozole; D047072:Aromatase Inhibitors / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000077289:Letrozole; D008875:Middle Aged; D009570:Nitriles / Q000009:adverse effects*; D012859:Sjogren's Syndrome / Q000139:chemically induced*; D014230:Triazoles / Q000009:adverse effects*
chemical_list: D047072:Aromatase Inhibitors; D009570:Nitriles; D014230:Triazoles; D000077384:Anastrozole; D000077289:Letrozole